Yuting Su

Nanning, 530021, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Low KIF26B Expression Reduces Paclitaxel Resistance and Predicts Good Prognosis in Ovarian Cancer.

Low KIF26B Expression Reduces Paclitaxel Resistance and Predicts Good Prognosis in Ovarian Cancer.

Journal: Current issues in molecular biology

Published: December 21, 2025

Low LAMA2 expression may affect drug resistance and prognosis in ovarian cancer via positive LGR5 coexpression.

Low LAMA2 expression may affect drug resistance and prognosis in ovarian cancer via positive LGR5 coexpression.

Journal: Translational cancer research

Published: October 09, 2025

Identification of multigene predictors of prognosis in patients with ovarian cancer.

Identification of multigene predictors of prognosis in patients with ovarian cancer.

Journal: iScience

Published: September 06, 2025

The dual role of SLC7A11 in tumor drug resistance: mechanisms, challenges, and therapeutic potential.

The dual role of SLC7A11 in tumor drug resistance: mechanisms, challenges, and therapeutic potential.

Journal: American journal of cancer research

Published: May 13, 2025

Correction to: Low FHL1 expression indicates a good prognosis and drug sensitivity in ovarian cancer.

Correction to: Low FHL1 expression indicates a good prognosis and drug sensitivity in ovarian cancer.

Journal: Functional & integrative genomics

Published: May 13, 2024

LAMC3 interference reduces drug resistance of carboplatin-resistant ovarian cancer cells.

LAMC3 interference reduces drug resistance of carboplatin-resistant ovarian cancer cells.

Journal: Scientific reports

Published: April 28, 2024

Upregulation of miRNA-450b-5p targets ACTB to affect drug resistance and prognosis of ovarian cancer via the PI3K/Akt signaling pathway.

Upregulation of miRNA-450b-5p targets ACTB to affect drug resistance and prognosis of ovarian cancer via the PI3K/Akt signaling pathway.

Journal: Translational cancer research

Published: February 24, 2024

Low FHL1 expression indicates a good prognosis and drug sensitivity in ovarian cancer.

Low FHL1 expression indicates a good prognosis and drug sensitivity in ovarian cancer.

Journal: Functional & integrative genomics

Published: November 22, 2023

Identification of genes predicting chemoresistance and short survival in ovarian cancer.

Identification of genes predicting chemoresistance and short survival in ovarian cancer.

Journal: Translational cancer research

Published: November 22, 2023

Identification of natural compound garcinone E as a novel autophagic flux inhibitor with anticancer effect in nasopharyngeal carcinoma cells.

Identification of natural compound garcinone E as a novel autophagic flux inhibitor with anticancer effect in nasopharyngeal carcinoma cells.

Journal: Pharmaceutical biology

Published: May 19, 2023

Sequence as a Whole: A Unified Framework for Video Action Localization With Long-Range Text Query.

Sequence as a Whole: A Unified Framework for Video Action Localization With Long-Range Text Query.

Journal: IEEE transactions on image processing : a publication of the IEEE Signal Processing Society

Published: April 06, 2023

Low Expression of SLC7A11 Confers Drug Resistance and Worse Survival in Ovarian Cancer via Inhibition of Cell Autophagy as a Competing Endogenous RNA.

Low Expression of SLC7A11 Confers Drug Resistance and Worse Survival in Ovarian Cancer via Inhibition of Cell Autophagy as a Competing Endogenous RNA.

Journal: Frontiers in oncology

Published: August 06, 2021

Showing 1-12 of 14

Last Updated: 09/26/2026